• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Clinical analysis of 12 acute leukemia patients aged over 80 years].

作者信息

Lin Jie, Zhu Hong-Li, Lu Xue-Chun, Fan Hui, Li Su-Xia, Zhai Bing, Liu Yang, Ran Hai-Hong, Yang Bo

机构信息

Department of Geriatric Hematology, Chinese PLA General Hospital, Beijing 100853, China.

出版信息

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):139-42.

PMID:21362239
Abstract

The objective of this study was to explore the clinical features of acute leukemia patients aged over 80 years. 12 cases of acute leukemia patients aged over 80 years who were diagnosed from 2000 to 2010 years were analyzed retrospectively. 9 cases suffered from acute myelogenous leukemia and 3 cases were with acute lymphoblastic leukemia. All patients were with several complicated diseases and the general status was poor in most patients. 10 cases received individualized treatments. The results showed that 2 patients achieved complete remission, but in other patients was not observed remission and the mean survival time was 20 ± 16 weeks. In AML patients, the mean survival time was 27 ± 14 weeks which was obviously longer than that in other reports. The survival time in 3 ALL patients was shortest. In conclusion, survival time was prolonged obviously in AML patients well advanced of age after individualized treatments, but prognosis of ALL in aged patients was very poor, for whom there is no relatively effective treatment.

摘要

相似文献

1
[Clinical analysis of 12 acute leukemia patients aged over 80 years].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):139-42.
2
Acute leukemia in patients sixty years of age and older: a twenty year single institution review.60岁及以上患者的急性白血病:一项为期20年的单机构回顾研究。
Am J Clin Oncol. 2009 Apr;32(2):137-41. doi: 10.1097/COC.0b013e31818a6c93.
3
Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985.
Jpn J Clin Oncol. 1989 Dec;19(4):338-47.
4
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.造血干细胞移植率与急性髓系白血病和急性淋巴细胞白血病的长期生存:来自瑞典急性白血病登记处 1997-2006 年真实世界的基于人群的数据。
Cancer. 2011 Sep 15;117(18):4238-46. doi: 10.1002/cncr.26033. Epub 2011 Mar 8.
5
Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.东欧各中心对首次完全缓解的急性白血病患者进行 HLA 匹配的亲缘异体造血干细胞移植的结果。近年来结果更佳。
Ann Hematol. 2009 Oct;88(10):1005-13. doi: 10.1007/s00277-009-0719-5. Epub 2009 Mar 20.
6
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关:日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
7
Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia.对于接受减低强度全身照射(TBI)与骨髓清除性 TBI 作为急性白血病异基因移植预处理的患者,其生存情况相似。
Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):360-9. doi: 10.1016/j.ijrobp.2014.02.032. Epub 2014 May 5.
8
[Treatment of childhood leukemia].[儿童白血病的治疗]
Gan No Rinsho. 1989 May;Spec No:345-52.
9
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.异基因骨髓移植后的长期生存与晚期死亡。国际骨髓移植登记处迟发效应工作委员会。
N Engl J Med. 1999 Jul 1;341(1):14-21. doi: 10.1056/NEJM199907013410103.
10
Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes.移植后白血病复发的第二次异基因骨髓移植:日本24家机构66例病例的调查结果
Bone Marrow Transplant. 1997 Mar;19(5):461-6. doi: 10.1038/sj.bmt.1700680.

引用本文的文献

1
Successful treatment with low-dose decitabine in acute myelogenous leukemia in elderly patients over 80 years old: Five case reports.低剂量地西他滨成功治疗80岁以上老年急性髓系白血病:5例病例报告。
Oncol Lett. 2013 Apr;5(4):1321-1324. doi: 10.3892/ol.2013.1139. Epub 2013 Jan 18.